|
|
||||||||




,
Departments of
*
Medicine and
Microbiology, University of Alabama, Birmingham, AL 35294; and the
Department of Veterans Affairs, Birmingham, AL 35233
| Abstract |
|---|
|
|
|---|
2 and Syk protein
tyrosine kinase were significantly higher in MZ cells than in FO cells
after mIgM engagement, providing a likely explanation for our previous
findings. Tyrosine phosphorylation of CD22 and expression of Src
homology 2-containing inositol phosphatase and Src homology
2-containing protein tyrosine phosphatase-1 were also higher in the MZ
cells. Expression and tyrosine phosphorylation of Btk, BLNK, Vav, or
phosphatidylinositol 3-kinase were equivalent. In contrast, stimulation
with anti-
induced equivalent increases in calcium and
activation of Syk in the two subsets. These signals were also
equivalent in cells from IgM transgenic, JH knockout mice,
which have equivalent levels of IgM in both subsets. With total spleen
B cells, Btk was maximally phosphorylated at a lower concentration of
anti-
than Syk. Thus, calcium signaling in the subsets of mature
B cells reflects the amount of Ig ligated more than the isotype or the
subset and this correlates with the relative tyrosine phosphorylation
of Syk. | Introduction |
|---|
|
|
|---|
Survival of mature B cells is dependent on expression of the B cell Ag receptor (BCR). Inducible deletion of the Ig V region leads to cell death (13). The specificity of the BCR determines the differentiation pathway taken by mature B cells. For example, in mice transgenic for either the VH81X or M167 heavy chains, B cells expressing heavy and light chain pairs that form the predominant, anti-phosphorylcholine Id are preferentially found in the MZ (12). The MZ subset, like the B-1 subpopulation, is enriched in cells that are likely to receive frequent binding signals through the BCR, as a result of weak anti-self reactivity or binding to widely expressed Ags (11). The autoreactive B-1 cells require the presence of the autoantigen to survive (14, 15). The similarity of the reactivities of MZ cells leads to the suggestion that the same is true for these (11). Thus, BCR-derived signals are likely to determine the phenotype of both B-1 and subsets of B-2 (also referred to as B0) cells.
Differences in signaling and responses between mature B-2 cells and immature cells or B-1 cells have been reported (16, 17, 18, 19, 20), but differences in BCR signaling pathways between subsets of mature B-2 cell subsets are largely uncharacterized. We previously found that MZ cells generate higher and more sustained calcium influxes after mIgM cross-linking than do FO or newly formed B cells (1). To understand this difference, we analyzed the cytoplasmic proteins important in the early events after BCR ligation, with emphasis on the mature FO and MZ subsets. Dose-response studies demonstrate that phosphorylation of Syk is more dose-dependent than that of Btk, providing a mechanism for the differences observed with anti-IgM. However, expression of most relevant molecules is equivalent in FO and MZ cells (except Src homology 2-containing protein tyrosine phosphatase-1 (SHP-1) and Src homology 2-containing inositol phosphatase (SHIP)), and the differences in signaling reflect total BCR expressed, rather than Ig isotype or subset of B cell, because FO cells with increased IgM, in IgM transgenic, JH knockout mice, respond similarly to MZ cells.
| Materials and Methods |
|---|
|
|
|---|
VH81X-C57BL/6 and
VH81X/JHko-C57BL/6
(21, 22) mice were bred and housed in our animal facility
in accordance with institutional policies for animal care and usage.
Mice were used at 812 wk of age. Anti-phosphotyrosine (4G10) and
anti-phosphatidylinositol 3-kinase (PI3K) p85 were purchased from
Upstate Biotechnology (Lake Placid, NY). Polyclonal rabbit Ab to Syk
(LR), phospholipase C-
2 (PLC
2) (Q20), PLC
1 (530), Btk (M138),
SHIP (M14), Fyn (FYN3), Lyn (15), Blk (K23), polyclonal goat Ab to BLNK
(C19), mAb to BLNK (2B11), and Fyn (15) were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Anti-CD22 (Cy34) is a gift of Dr. L.
Justement. Polyclonal rabbit Ab to Btk was from PharMingen (San Diego,
CA). mAb to SHP-1 was from Transduction Laboratories (Lexington, KY).
Peroxidase-coupled rabbit anti-mouse IgG and mouse anti-rabbit
IgG were purchased from Jackson Immunoresearch (West Grove, PA).
Peroxidase-coupled swine anti-goat IgG was purchased from Roche
Molecular Biochemicals (Indianapolis, IN). Anti-CD23-FITC was from
PharMingen. F(ab')2 polyclonal goat
anti-mouse was purchased from Southern Biotechnology Associates
(Birmingham, AL). Anti-Thy-1.2 (30H12), anti-CD4 (GK1.5),
anti-CD19 (1D3), anti-CD21(7G6)-PE, and anti-CD5-FITC were
prepared by us.
Cell preparation and sorting
MZ, FO, and/or newly formed cells were separated by cell sorting
as previously described (1). Briefly, single-cell
suspensions were made from three to six mouse spleens. Red cells were
depleted by lysis with an ammonium chloride-containing buffer. T cells
were removed by treatment with anti-Thy-1.2 and anti-CD4 Ab and
rabbit complement (Accurate Chemicals, Westbury, NY). Viable cells were
recovered by centrifugation over a lymphocyte M gradient (Cedarlane
Laboratories, Hornby, Ontario, Canada) at 900 x g. B
cells were incubated with a mixture of anti-CD5-FITC,
anti-CD23-FITC, anti-CD21-PE, and, in some experiments,
anti-B220-PE/Cy5 (activation assays) or anti-CD19-PE/Cy5 (cell
surface expression assays) for 15 min, washed, and resuspended in 2%
FCS (HyClone, Logan, UT) in PBS. MZ, FO, and newly formed cells were
sorted based on their differential expression of CD21 and CD23 using a
FACSVantage SE (Becton Dickinson, Mountain View, CA). Typical sort
profiles are shown in Fig. 6
. B-1a cells were excluded by expression of
CD5. We have previously provided evidence that using anti-CD21 and
anti-CD23 Ab to sort did not alter the character of the calcium
response because sorting with other markers gave similar results
(1).
|
Splenic B cells were stimulated in HBSS containing 0.1% BSA, 1
mM MgCl2, and 1 mM CaCl2
with 20 µg/ml F(ab')2 polyclonal goat
anti-mouse IgM or anti-
. The cells were centrifuged and the
pellets lysed with Nonidet P-40 lysis buffer as previously described
(23). Lysates were cleared by centrifugation at 14,000 rpm
for 10 min at 4°C. For whole cell lysate (WCL) immunoblotting,
lysates were prepared from 1 x 106
cells/lane. Immunoprecipitations were prepared from lysates of
24 x 106 cells/lane by addition of
appropriate Ab (210 µg/ml), followed by protein A-Trisacryl or
protein G gel (Pierce, Rockford, IL). The washed precipitates were
eluted in, and WCL were mixed with, 2x Laemmli sample buffer with 0.1
M DTT for 5 min. Proteins were resolved by SDS-PAGE, transferred to
nitrocellulose, probed with Ab as indicated, and detected by
peroxidase-coupled anti-mouse or anti-rabbit (1:10,000) as
appropriate, followed by chemiluminescence (Amersham, Arlington
Heights, IL).
In vitro Syk protein kinase assay
The in vitro kinase assay was as described by Umehara et al.
(24). Briefly, immunoprecipitates were prepared from
clarified lysates by incubation with anti-Syk antisera and protein
A-Trisacryl, washed four times with lysis buffer, once with kinase
buffer (25 mM HEPES, pH 7.4; 0.1% Nonidet P-40; 10 mM
MgCl2, 10 mM MnCl2; and 1
mM Na3VO4), and incubated
with 30 µl of the kinase buffer containing 5 µg of GST-heat shock 1
(GST-HS-1) as the substrate (25) and 10 µCi
[
-32P]ATP for 10 min at 30°C. The
reactions were terminated by adding 30 µl of 2X Laemmli sample buffer
and boiling with for 5 min. Proteins were resolved on a 10%
SDS-polyacrylamide gel. Incorporation of 32P into
GST-HS-1 was analyzed by autoradiography and with a phosphor imager
(FUJIX BAS1000; FUJIX, Tokyo, Japan).
In vitro PLC
2 activity and inositol 1,4,5-trisphosphate
(IP3) assays
PLC
2 activity was determined in vitro using
[3H]phosphatidylinositol 4,5-biphosphate
(PIP2) as substrate (26). PLC
2
immunoprecipitates prepared from clarified lysates were washed with
Nonidet P-40 lysis buffer, passed over a 20% sucrose cushion, washed
with assay buffer (35 mM
NaH2PO4, pH 6.8; 70 mM KCl,
0.8 mM CaCl2, 0.8 mM EGTA; and 0.05% Triton
X-100), and incubated with 50 µl of assay buffer containing 200 µM
[3H]PIP2 (0.022 uCi, New
England Nuclear Products) at 37°C for 15 min. The reaction was
stopped by the addition of 100 µl of 1% BSA and 250 µl of ice-cold
10% trichloroacetic acid. The samples were centrifuged at 14,000 rpm
for 4 min and the resulting supernatant containing released
[3H]inositol phosphates was counted by liquid
scintillation. IP3 levels in cellular extracts
were measured by a
D-myo-[3H]IP3
assay system (Amersham).
| Results |
|---|
|
|
|---|
5% of normal adult mouse splenic B
cells. The percentage of MZ cells is increased to
15% in heavy
chain VH81X transgenic mice, which generate B cells expressing
VH81X-DFL16-JH1 rearranged heavy chain, which combines with endogenous
light chain (21, 27). The dominant Id in these mice
preferentially migrates to the MZ. MZ and FO cells from the transgenic
mice and normal C57/Bl6 mice share similar functional characteristics
and calcium responses to BCR ligation (1, 10). We also
found that the pattern of tyrosine phosphorylation after ligation of
mIgM was similar in splenic B cell subsets in VH81X and nontransgenic
mice (data not shown). Therefore, we have used these transgenic mice as
a source of the larger quantities of purified MZ cells necessary for
the biochemical analysis of individual molecules in studies of mIgM
signaling. mIgM-induced tyrosine-mediated signaling in splenic B cells
BCR signaling is initiated by activation of protein tyrosine
kinases. Having previously found that BCR-induced calcium changes were
greater in MZ than in other subsets of splenic B cells, we asked
whether changes in protein tyrosine phosphorylation also differed
between the subsets. Splenic mononuclear cells were depleted of T cells
and sorted for newly formed (CD21low,
CD23low), FO
(CD21intermediate,
CD23high) or MZ (CD21high,
CD23low) B220+ B cells.
Lysates from equal numbers of cells of each type were analyzed for
phosphotyrosine content (Fig. 1
, top). Ligation of mIgM induced tyrosine phosphorylation of
proteins in each subset. The phosphotyrosine content of multiple
proteins was greater in MZ than in FO and newly formed cells. However,
the enhanced protein tyrosine phosphorylation in MZ cells is selective.
Certain proteins (open arrows) were tyrosine-phosphorylated in all
subsets. To standardize the blot to the
Mr of known proteins, the blot was
stripped and reprobed with anti-PLC
2 and anti-Syk antisera.
The relative migration (i.e., not identity) of these is indicated by
solid arrows. Results of the reprobe with anti-PLC
2 are shown to
demonstrate equal loading (Fig. 1
, bottom). The
phosphotyrosine content of multiple proteins seems to be greater in MZ
cells, but the increase is selective and not simply a global
enhancement.
|
2 in MZ cells after stimulation with
anti-IgM
The greater mIgM-induced increase in protein phosphotyrosine
content in MZ cells suggests that increased tyrosine phosphorylation of
PLC
2 could provide a mechanism for the enhanced increase in calcium
in these cells that we reported previously (1). To test
this, MZ and FO cells were stimulated with either PBS or
F(ab')2 polyclonal goat anti-mouse IgM and
lysed. PLC
2 was immunoprecipitated and sequentially probed with
anti-phosphotyrosine and anti-PLC
2 Ab. The phosphotyrosine
content of PLC
2 after mIgM cross-linking was significantly higher in
MZ cells than in FO cells (Fig. 2
A, top). Reprobing
with anti-PLC
2 revealed equivalent expression of PLC
2 in both
subsets (Fig. 2
A, bottom). PLC
2 is more
abundant and more heavily tyrosine-phosphorylated than PLC
1 in
murine B cells after mIgM ligation (28, 29, 30). Consistent
with these reports, we found that although PLC
1 was expressed in
both MZ and FO cells, little tyrosine-phosphorylated PLC
1 was
detected in either subset after mIgM cross-linking (data not shown). In
other experiments, although the difference in tyrosine phosphorylation
of PLC
2 between anti-IgM-stimulated MZ and FO cells was a
consistent observation at early time points, the difference was less
apparent at 30 min (data not shown).
|
2, which, along with membrane localization,
activates the enzyme (28). However, in some cells the
activity of PLC
does not correlate with its phosphorylation
(17). We measured the enzymatic activity of PLC
2
immunoprecipitated from FO and MZ cells that were stimulated with PBS
only or with F(ab')2 anti-IgM for 1 min. The
activation-induced increase in PLC
2 activity observed in stimulated
MZ cells was 2.5-fold greater than the increase in activity in
stimulated FO cells (Fig. 2
2 activity as
well as tyrosine phosphorylation is increased in MZ cells. We also
measured IP3 production in MZ and FO cells after
stimulation for 1 min with F(ab')2 anti-IgM.
The increase in IP3 in MZ cells was twice that in
FO cells (data not shown). The increased phosphorylation and activity
of PLC
2 and IP3 generation in MZ cells
stimulated with anti-IgM provides a likely explanation for the
greater increase in calcium previously observed after ligation of mIgM
in these cells. Syk tyrosine phosphorylation and activity is greater in MZ than in FO cells after mIgM stimulation
Syk plays a central role in coupling the BCR to PLC
2 (31, 32). The kinase activity of Syk is dependent on its tyrosine
phosphorylation after BCR cross-linking (33, 34). We asked
whether Syk was differentially tyrosine phosphorylated and activated in
the two subsets after ligation of mIgM. Immunoprecipitates prepared
with anti-Syk antisera from MZ or FO cells stimulated with PBS or
with F(ab')2 anti-IgM for 1, 5, or 30 min
were analyzed by immunoblotting (Fig. 3
A). After mIgM cross-linking,
phosphotyrosine content of Syk in MZ cells was markedly enhanced, while
only a small increase in Syk tyrosine phosphorylation was detected in
FO cells. The difference persisted to 30 min. The blots were stripped
and reprobed with anti-Syk antisera, demonstrating that the amount
of Syk protein recovered was equivalent in all samples. In vitro kinase
assays were used to measure the activity of immunoprecipitated Syk.
After mIgM cross-linking for 1 min, Syk activity increased by 2.5-fold
in MZ cells, compared with 1.3-fold in FO cells (Fig. 3
B).
Thus, although Syk is expressed equivalently in MZ and FO cells, the
tyrosine phosphorylation and activity of Syk after ligation of mIgM are
both higher in MZ cells after stimulation with anti-IgM.
|
2
(32, 35). Btk activation after cross-linking of the BCR is
correlated with tyrosine phosphorylation and association with the
plasma membrane (36). We examined tyrosine phosphorylation
of Btk in MZ and FO cells. Although tyrosine phosphorylation of Btk
increased similarly after mIgM ligation in both cells, both basal and
activation-induced phosphotyrosine content of Btk was slightly higher
in FO cells than in MZ cells (Fig. 3
Src family kinases may link the BCR to downstream kinases. To determine
whether the difference in PLC
2 tyrosine phosphorylation between MZ
and FO cells reflects differential expression levels of these kinases,
protein levels of Lyn, Fyn, and BLK as well as Syk and Btk were
examined in WCL from equivalent numbers of MZ and FO cells. Comparable
levels of Lyn, Fyn, and Blk were present in both types of cells (Fig. 4
). As yet, we have been unable to detect
reproducible increases in tyrosine phosphorylation or activity of these
kinases, presumably reflecting only the restricted numbers of cells
attainable in this system.
|
|
The mIgM-induced increase in intracellular calcium and in tyrosine
phosphorylation of multiple proteins in MZ is greater than in either
newly formed or FO cells. The expression of mIgM on newly formed cells
is equivalent to MZ cells, so the differences observed between these
subsets likely reflect other factors. However, the expression of IgM on
FO cells is less than that of MZ cells. To determine whether the
differences observed in signaling between MZ and FO cells reflect
differences in total BCR expression, we analyzed calcium responses in
MZ and FO cells from normal C57BL/6 mice. These express both IgM and
IgD. The IgD is expressed at higher levels in the FO than in the MZ
cells (the inverse of IgM expression) (Fig. 6
). When these cells were stimulated with
anti-IgM the calcium response was again greater in MZ cells.
However, stimulation with anti-IgD induced a greater calcium
response in the FO cells (Fig. 7
). In
contrast, two different concentrations of anti-
produced
equivalent calcium responses in both subsets. To determine whether the
relative increase in calcium in FO cells correlated with an increase in
total tyrosine phosphorylation of cellular proteins, WCL were obtained
from MZ and FO cells that were stimulated with buffer only or with
20µg/ml of F(ab')2 anti-
and
sequentially probed for phosphotyrosine and PLC
2. Unlike the results
with anti-IgM (Fig. 1
), the increase in phosphotyrosine content
was, for most bands, equivalent in cells from the two subsets (Fig. 8
). A few bands remained more intensely
phosphorylated in MZ cells (open arrow), but whether this represents
differential expression or kinase activity is unknown.
|
|
Syk and PLC
2 were immunoprecipitated to determine whether
anti-
-induced tyrosine phosphorylation of these correlated with
the relative increase in calcium response induced by anti-
in FO
cells, compared with MZ cells. When total BCR was cross-linked with
anti-
, the tyrosine phosphorylations of Syk and PLC
2 were
equivalent in these subsets (Fig. 9
A). To determine whether the
relative increase in phosphorylation of Syk and PLC
2 observed in the
normal mice was dependent on the isotype expressed, we took advantage
of the increased expression of IgM in FO cells when the VH81X transgene
is crossed onto the JH knockout background. In
these mice, the levels of expression of IgM in the FO cells are
increased and approximate that on MZ cells (see Fig. 6
; TG
JHko). When stimulated with anti-
, the
BCR-induced tyrosine phosphorylations of Syk and PLC
2 were
equivalent in the MZ and FO subsets in these mice (Fig. 9
B).
|
. This was consistent with the
observation in the WCLs from MZ and FO cells stimulated with
anti-IgM, in which certain proteins were equivalently
phosphorylated while others were different (Fig. 1
(Fig. 10
were measured. The
data were normalized such that the level of phosphorylation of each
enzyme stimulated with PBS was set to a value of 0 and the level
induced by 20µg/ml of anti-
to 1. Btk phosphorylation is near
maximal at 5µg/ml. Equivalent results were also seen in dose-response
studies of anti-IgM-stimulated MZ cells (data not shown). Thus, Syk
requires greater BCR ligation to induce a given percentage of its
maximal response (although Syk phosphorylation may not be saturated and
might be further increased by concentrations of anti-
>20
µg/ml, this would only increase the contrast with Btk). This also
provides a mechanism for the different magnitude of calcium responses
in MZ and FO cells stimulated with anti-IgM. The expression of
different kinases that require different levels of BCR ligation to
become activated is to be expected. Our results suggest that Syk
requires a stronger BCR signal to become fully activated and that this
correlates with phosphorylation of PLC
2 and the calcium response in
the FO and MZ cells from the normal, transgenic, or transgenic
JH knockout mice.
|
| Discussion |
|---|
|
|
|---|
2 in MZ cells provides a likely
mechanism for the higher mIgM-induced increase in calcium response we
previously reported in these cells. A greater increase in both tyrosine
phosphorylation and activity of Syk correlates with the increased
activation of PLC
2 and the calcium response. An association of
PLC
with Syk has been described (although the reagents used were for
PLC
1) and Syk is required for activation of PLC
2 (31, 43). The simplest explanation is that increased activity of Syk
leads to increased PLC
2 activity when MZ cells are stimulated with
anti-IgM. However, our data also suggest that the differences in
IgM-induced activation of Syk between MZ and FO cells are due to
differences in IgM expression rather than to differentiation-induced
changes in signaling pathways. Increased expression of IgM on FO cells,
in VH81x/JH ko mice, or ligation of more BCR on
FO cells, using anti-
, lead to equal activation of Syk between
FO and MZ cells. The finding that expression levels of Src family and
Syk kinases and Btk and BLNK are equivalent in the two cell types is
consistent with the conclusion that the linkage between the BCR and
PLC
are similar in MZ and FO cells.
Syk also phosphorylates BLNK, which forms a docking site for PLC
2
and for Btk. Both BLNK and Btk are required for activation of PLC
2
in DT40 cells (32, 35). However, in contrast to Syk, the
mIgM-induced increase in tyrosine phosphorylation of BLNK and Btk is
equivalent in MZ and FO cells. Thus, in normal mouse cells, a relative
increase in activity of Syk correlates with a greater tyrosine
phosphorylation of PLC
2 but does not lead to a further increase in
phosphorylation of BLNK. If Syk is the dominant kinase responsible for
phosphorylation of BLNK, then the relative requirements for full
activation Syk to maximally phosphorylate BLNK and PLC
2 differ.
Tyrosine phosphorylation of both BLNK and Btk increased after
activation in both subsets, so our data do not argue against an
association of BLNK, Btk, and PLC
, only that, in normal mouse cells,
the maximal tyrosine phosphorylation of PLC
2 correlates with full
activation of Syk. Interestingly, although Btk enhances the late phase
of calcium responses, PLC
2 was tyrosine phosphorylated equivalently
in B cell lines derived from normal or XLA patients (44, 45). Our hypothesis is that PLC
2 is a substrate for both Syk
and Btk, but with different saturation at differing levels of BCR
ligation. This hypothesis is supported by the greater phosphorylation
of PLC
at later time points, when activity of Syk is still minimal,
in FO cells, and the observation of low-level phosphorylation of PLC
at limiting doses of anti-
.
Different dose-response characteristics for Syk vs Btk may provide a
mechanism for differing thresholds for activation of downstream
pathways. Comparison of the anti-phosphotyrosine immunoblots of
WCLs of MZ and FO cells, stimulated with either anti-IgM or
anti-
, suggests that the phosphorylation of a subset of cellular
proteins correlates with that of Syk and PLC, while others are less
dose-dependent, as observed with Btk and BLNK, consistent with this
hypothesis of differing thresholds for activation of different
pathways.
Surprisingly, expression of SHP-1 and SHIP and tyrosine phosphorylation
of CD22 were also higher in anti-IgM-stimulated MZ cells. Although
CD22 has variable effects on B cell Ab responses, CD22-deficient mice
have increased calcium responses to BCR ligation, perhaps as a result
of loss of localization of SHP-1 (46, 47, 48). However, CD22
also binds positive regulators of BCR signaling, including Syk and
PLC
1 (testing of PLC
2 has not been reported) (43, 49). CD22 and PLC
may be more heavily phosphorylated in the
anti-IgM-stimulated MZ simply as separate downstream substrates for
Syk, but an alternative possibility is that CD22 may link PLC
and
Syk. In addition, differential saturation of different CD22 tyrosines
by kinases with different dose-response characteristics could lead to
altered ratios of binding of positive and negative regulators after
different levels of BCR ligation. Finally, the stimulation conditions
used here would not have engaged Fc receptors or paired IgR-like
molecules, and, thus, mechanisms of inhibition that use SHIP or SHP-1
were not fully activated.
Our observations reflect the signaling component that underlies recent studies showing alterations in B cell differentiation with different levels of BCR expression. B-1 vs B-2 differentiation was determined by the level of surface expression of a transgenic anti-erythrocyte Ig, compared between mice heterozygous and homozygous for the transgene, or by dilution of an autoreactive VH12 IgH transgene by coexpression with a VHB18 transgene (50, 51). Similarly, transgene copy number determined the surface phenotype of (unedited) mature B-2 cells (52). Our results demonstrate that studies that compare signaling between populations of B cells, which may either segregate to different compartments or alter expression of membrane Ig, must consider whether differences in signaling are due to alterations in Ig expression levels. Our findings demonstrate how BCR expression level regulates BCR signaling in mature subsets of mouse B-2 cells. The expression-related differences in signaling are not global, but differentially alter particular enzymes, such as Syk, PLC, and Btk, as determined by their dose-response relationship to BCR ligation.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Robert H. Carter, 409 LHRB, Division of Clinical Immunology and Rheumatology, University of Alabama, 701 South 19th Street, Birmingham, AL 35294-0007. ![]()
3 Abbreviations used in this paper: FO, follicular mantle; MZ, marginal zone; mIgM, membrane IgM; BCR, B cell Ag receptor; SHP-1, Src homology 2-containing protein tyrosine phosphatase-1; SHIP, Src homology 2-containing inositol phosphatase; PI3K, phosphatidylinositol 3-kinase; PLC, phospholipase C; WCL, whole cell lysate; GST-HS-1, GST-heat shock-1; IP3, inositol 2,4,5-trisphosphate; PIP2, phosphatidylinositol 4,5-biphosphate. ![]()
Received for publication October 19, 2000. Accepted for publication December 2, 2000.
| References |
|---|
|
|
|---|
+
+ and static
+
+ B lymphocyte subsets. Eur. J. Immunol. 12:564.[Medline]
2 in B-1 lymphocytes. Int. Immunol. 6:1011.
B cells are unable to complete all developmental programs. J. Immunol. 160:3748.
1 by tyrosine phosphorylation. Science 250:1253.
2 upon cross-linking of membrane Ig on murine B lymphocytes. J. Immunol. 148:3021.[Abstract]
2 and Rac1-JNK in B cells. Immunity 10:117.[Medline]
2. J. Exp. Med. 194:31.
RIIB. Nature 383:263.[Medline]
1 upon B cell activation. J. Exp. Med. 183:547.This article has been cited by other articles:
![]() |
B. R. Herrin and L. B. Justement Expression of the Adaptor Protein Hematopoietic Src Homology 2 is Up-Regulated in Response to Stimuli That Promote Survival and Differentiation of B Cells J. Immunol., April 1, 2006; 176(7): 4163 - 4172. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Phan, S. Gardam, A. Basten, and R. Brink Altered Migration, Recruitment, and Somatic Hypermutation in the Early Response of Marginal Zone B Cells to T Cell-Dependent Antigen J. Immunol., April 15, 2005; 174(8): 4567 - 4578. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Donahue, K. L. Hess, K. L. Ng, and D. A. Fruman Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85{alpha} Int. Immunol., December 1, 2004; 16(12): 1789 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Attanavanich and J. F. Kearney Marginal Zone, but Not Follicular B Cells, Are Potent Activators of Naive CD4 T Cells J. Immunol., January 15, 2004; 172(2): 803 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Tangye, D. T. Avery, E. K. Deenick, and P. D. Hodgkin Intrinsic Differences in the Proliferation of Naive and Memory Human B Cells as a Mechanism for Enhanced Secondary Immune Responses J. Immunol., January 15, 2003; 170(2): 686 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Itoh, M. Itoh, K. Nishida, S. Yamasaki, Y. Yoshida, M. Narimatsu, S. J. Park, M. Hibi, K. Ishihara, and T. Hirano Adapter Molecule Grb2-Associated Binder 1 Is Specifically Expressed in Marginal Zone B Cells and Negatively Regulates Thymus-Independent Antigen-2 Responses J. Immunol., May 15, 2002; 168(10): 5110 - 5116. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||